Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Douglas Anderson

Thoracic Surgery (Cardiothoracic Vascular Surgery) Baltimore, MD Doctor of Osteopathy

NPI 1124400759 CMS profile 1320336

419 W Redwood St Ste 300, Baltimore, MD 21201

Open in the dashboard

General payments

$22,825

157 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Douglas Anderson of Baltimore, MD is reported in the CMS Open Payments database as having received $22,825 across 157 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 81st percentile of Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $9,721 29
2024 General $3,074 36
2023 General $4,400 19
2022 General $524 4
2021 General $3,438 62
2019 General $1,667 7

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Douglas Anderson
  • Thoracic Surgery (Cardiothoracic Vascular Surgery) median
  • Middle half of Thoracic Surgery (Cardiothoracic Vascular Surgery)
  • National median

In program year 2025, general payments to Douglas Anderson were reported at $9,721. Among 4,073 Thoracic Surgery (Cardiothoracic Vascular Surgery) profiles paid that year, the median was $791 and the middle half received between $208 and $3,074.

Show as a table
Year Douglas Anderson Thoracic Surgery (Cardiothoracic Vascular Surgery) median Middle half National median
2019 $1,667 $886 $178–$3,167 $163
2020 $0 $341 $108–$1,605 $114
2021 $3,438 $453 $125–$1,886 $132
2022 $524 $695 $180–$2,566 $149
2023 $4,400 $745 $205–$2,662 $160
2024 $3,074 $799 $214–$2,967 $164
2025 $9,721 $791 $208–$3,074 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $12,757 47 payments
  2. AngioDynamics, Inc. $3,559 7 payments
  3. Atricure, Inc. $2,833 26 payments
  4. Boston Scientific Corporation $1,652 6 payments
  5. Medtronic, Inc. $1,071 17 payments
  6. CryoLife, Inc. $413 40 payments
  7. Penumbra, Inc. $114 1 payment
  8. Medical Device Business Services, Inc. $108 1 payment
  9. Ethicon US, LLC $55 2 payments
  10. Haemonetics Corporation $46 1 payment
  11. Other $215 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Travel and Lodging $9,572 65 payments
  2. Food and Beverage $7,352 88 payments
  3. Consulting Fee $5,565 2 payments
  4. Education $337 2 payments
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $9,124 22 payments
  2. ANGIOVAC $3,559 7 payments
  3. SYNERGY ABLATION SYSTEM $2,331 21 payments
  4. EVOQUE $1,861 8 payments
  5. General Therapies $1,652 6 payments
  6. AtriCure cryoICE cryoSPHERE Cryoablation System $939 9 payments
  7. SAPIEN 3 Ultra RESILIA $633 11 payments
  8. ATRICLIP LAA EXCLUSION SYSTEM $587 6 payments
  9. Octopus $487 8 payments
  10. Cardiac non-SynerGraft $413 40 payments
  11. Other $1,498 24 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 50 billing codes

Paid by Medicare

$160,928

Medicare's payments for the services billed

Medicare patients

199

Average age 76

Services billed

327

84 women, 115 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 60%
Diabetes 52%
Arthritis 49%
Atrial fibrillation 48%
Chronic kidney disease 48%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

157 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Thoracic Surgery (Cardiothoracic Vascular Surgery) in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record